1. European recalls of counterfeit schizophrenia drug

   News item 12 August 2017 Pages: 1 - 1

2. Risk of cardiac AEs with domperidone: HPRA reminder

   News item 12 August 2017 Pages: 2 - 2

3. Risk of kidney disease with atazanavir-containing products

   News item 12 August 2017 Pages: 3 - 3

4. Serious ADRs with ocular triamcinolone/moxifloxacin product

   News item 12 August 2017 Pages: 4 - 4

5. TGA introduces labelling changes to improve medicine use

   News item 12 August 2017 Pages: 5 - 5

6. TGA seeks comments on naming of biological products

   News item 12 August 2017 Pages: 6 - 6

7. Adverse events after HPV vaccine in Japanese adolescent girls

   Clinical study 12 August 2017 Pages: 7 - 7

8. Association between regular thyroxin use and thyroid cancer

   Clinical study 12 August 2017 Pages: 8 - 8

9. Facebook mentions regarding statins and side effects

   Clinical study 12 August 2017 Pages: 9 - 9

10. Opioids and psychotropic drugs: neonatal drug withdrawal

    Clinical study 12 August 2017 Pages: 10 - 10

11. Oral methylprednisolone in patients with IgA nephropathy

    Clinical study 12 August 2017 Pages: 11 - 11

12. Semi-automated pharmacoepidemiology studies

    Clinical study 12 August 2017 Pages: 12 - 12

13. Abciximab

    Case report 12 August 2017 Pages: 13 - 13

14. Abiraterone

    Case report 12 August 2017 Pages: 14 - 14

15. Acenocoumarol

    Case report 12 August 2017 Pages: 15 - 15

16. Acetazolamide

    Case report 12 August 2017 Pages: 16 - 16

17. Acetylcysteine

    Case report 12 August 2017 Pages: 17 - 17

18. Aciclovir

    Case report 12 August 2017 Pages: 18 - 18

19. Adalimumab

    Case report 12 August 2017 Pages: 19 - 19

20. Adalimumab/etanercept

    Case report 12 August 2017 Pages: 20 - 20

21. Adalimumab/etanercept

    Case report 12 August 2017 Pages: 21 - 21

22. Adalimumab/etanercept

    Case report 12 August 2017 Pages: 22 - 22

23. Adalimumab/infliximab/tocilizumab

    Case report 12 August 2017 Pages: 23 - 23

24. Adefovir

    Case report 12 August 2017 Pages: 24 - 24

25. Afatinib/amrubicin/oxycodone

    Case report 12 August 2017 Pages: 25 - 25

26. Alemtuzumab

    Case report 12 August 2017 Pages: 26 - 26

27. Alemtuzumab/idelalisib

    Case report 12 August 2017 Pages: 27 - 27

28. Alendronic acid

    Case report 12 August 2017 Pages: 28 - 28

29. Alendronic acid/colecalciferol

    Case report 12 August 2017 Pages: 29 - 29

30. Alendronic acid/zoledronic acid

    Case report 12 August 2017 Pages: 30 - 30

31. Amiodarone

    Case report 12 August 2017 Pages: 31 - 31

32. Amisulpride

    Case report 12 August 2017 Pages: 32 - 32

33. Amlodipine overdose

    Case report 12 August 2017 Pages: 33 - 33

34. Amlodipine overdose

    Case report 12 August 2017 Pages: 34 - 34

35. Amlodipine/labetolol overdose

    Case report 12 August 2017 Pages: 35 - 35

36. Amoxicillin/carbimazole/dipyrone

    Case report 12 August 2017 Pages: 36 - 36

37. Amoxicillin/clavulanic acid/antiepileptic drugs

    Case report 12 August 2017 Pages: 37 - 37

38. Amphotericin B liposomal

    Case report 12 August 2017 Pages: 38 - 38

39. Amphotericin B liposomal/flucytosine/voriconazole

    Case report 12 August 2017 Pages: 39 - 39

40. Amphotericin B/prednisone/tacrolimus

    Case report 12 August 2017 Pages: 40 - 40

41. Anticoagulants and antiplatelets

    Case report 12 August 2017 Pages: 41 - 41

42. Antidepressants

    Case report 12 August 2017 Pages: 42 - 42

43. Antifungals/antituberculars

    Case report 12 August 2017 Pages: 43 - 43

44. Antihyperglycaemics

    Case report 12 August 2017 Pages: 44 - 44

45. Antihypertensives

    Case report 12 August 2017 Pages: 45 - 45

46. Antineoplastics

    Case report 12 August 2017 Pages: 46 - 46

47. Antineoplastics

    Case report 12 August 2017 Pages: 47 - 47

48. Antipsychotics

    Case report 12 August 2017 Pages: 48 - 48

49. Antivirals

    Case report 12 August 2017 Pages: 49 - 49

50. Apomorphine

    Case report 12 August 2017 Pages: 50 - 50